Share
𝕏 Facebook LinkedIn

Anticancer and antibacterial potentials induced post short-term exposure to electromagnetic field and silver nanoparticles and related pathological and genetic alterations: in vitro study.

AI: Melanie Research RF Safe Research Library Jan 1, 2022 NEUTRAL LOW

This in vitro study evaluated short-term extremely low frequency electromagnetic field (ELF-EMF) exposure and silver nanoparticles (AgNPs), alone and combined, for antibacterial effects and apoptosis induction in MCF-7 breast cancer cells. The authors report time-dependent reductions in bacterial viable counts, with the combination condition (ELF-EMF + 10 µM/ml AgNPs for 2 h) reaching 100% inhibition for K. pneumoniae. They also report increased apoptosis and cell-cycle alterations, alongside changes in expression of p53, iNOS, NF-kB, Bcl-2, and miRNA-125b, which they suggest may relate to oxidative stress.

Key points

  • The study is an in vitro assessment of ELF-EMF and silver nanoparticles (AgNPs) as antibacterial and anticancer agents.
  • Bacterial outcomes were measured using viable count reduction in K. pneumoniae and S. aureus.
  • The authors report stronger antibacterial effects for K. pneumoniae than for S. aureus, with time-dependent reductions.
  • A combined condition (ELF-EMF + 10 µM/ml AgNPs for 2 h) was reported to achieve 100% inhibition for K. pneumoniae.
  • Apoptosis in MCF-7 cells was assessed by Annexin V-FITC and cell-cycle analysis and was reported to increase after ELF-EMF or AgNPs.
  • The apoptotic effect was reported to be intensified under combined ELF-EMF and AgNP exposure, with increased Pre G1 fraction versus control.
  • Cell-cycle effects differed by agent, with S phase arrest reported for AgNPs and G2/M accumulation reported for EMF.
  • Gene expression changes included up-regulation of p53, iNOS, and NF-kB and down-regulation of Bcl-2 and miRNA-125b after treatment.

Referenced studies & papers

Source: Open original

AI-generated summaries may be incomplete or incorrect. This content is for informational purposes only and is not medical advice.

Comments

Log in to comment.

No comments yet.